{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T09:26:35Z","timestamp":1794821195367,"version":"4.9.1"},"reference-count":20,"publisher":"Bentham Science Publishers Ltd.","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMIR"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The aim of this study was to explore the application of IVIM-DWI (intravoxel incoherent motion diffusion-weighted imaging) MRI (magnetic\nresonance imaging) in the evaluation of abnormal enhancement of the margin of hepatocellular carcinoma (HCC) after radiofrequency ablation\n(RFA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>We performed a routine IVIM-DWI imaging review of patients who had been diagnosed with HCC and had received RFA in the past four years.\nWe made quantitative comparisons of D, D*, and f in different tissues and lesions, and used one-way analysis of variance to compare quantitative\ndata and an ROC (receiver operating characteristic) curve to analyze the diagnostic efficacy of the data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 79 patients met the study\u2019s criteria. The consistency of the measured values of the three surveyors was very good (ICC &gt; 0.90). The D of\nrecurrent HCC and the inflammatory reaction zone was (0.65 \u00b1 0.16) \u00d7 10\u22123 mm2\/s and (0.87 \u00b1 0.05) \u00d7 10\u22123 mm2\/s, respectively. The D* of\nrecurrent HCC and the inflammatory reaction zone was (31.34 \u00b1 11.54) \u00d7 10\u22123 mm2\/s and (41.37 \u00b1 5.11) \u00d7 10\u22123 mm2\/s, respectively. The f of\nrecurrent HCC and the inflammatory reaction zone was (18.16 \u00b1 5.82)% and (24.21 \u00b1 3.69)%, respectively. The differences in IVIM-DWI\nparameters between the two groups were all statistically significant (P &lt; 0.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Our research indicated that the D of recurrent HCC was lower than that of the inflammatory reaction zone. The optimal cutoff value can\ndifferentiate between these two types of lesions. Our research revealed a statistically significant difference in D* between recurrent HCC and the\ninflammatory reaction zone. The ROC curve shows that this optimal cutoff value has high diagnostic efficiency. The f is higher in hepatic\nparenchyma and inflammatory reaction zones than in other tissues. Therefore, f may help distinguish the inflammatory reaction zone from\nrecurrent HCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>IVIM-DWI is valuable for differentiating between regions of recurrent HCC and the inflammatory reaction zone in post-RFA tumors. In terms of\ndiagnostic performance, D outperformed D* and f.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115734056468200260622070740","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:40:07Z","timestamp":1784004007000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intravoxel Incoherent Motion Diffusion-Weighted MR Imaging can Differentiate between Residual or Recurrent Hepatocellular Carcinoma and Inflammatory Reaction Zone: A Single-Center Study"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4421-3836","authenticated-orcid":true,"given":"Yuchang","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Radiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100043, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5491-0398","authenticated-orcid":true,"given":"Xuechao","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100043, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5933-9277","authenticated-orcid":true,"given":"Yufei","family":"Lian","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100043, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0650-933X","authenticated-orcid":true,"given":"Erhu","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1197-2206","authenticated-orcid":true,"given":"Zhenyu","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100043, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"101651","DOI":"10.1016\/j.tranon.2023.101651","volume":"31","author":"Peng W.","year":"2023","unstructured":"Peng W.; Bai S.; Zheng M.; Chen W.; Li Y.; Yang Y.; Zhao Y.; Xiong S.; Wang R.; Cheng B.; An exosome-related lncRNA signature correlates with prognosis, immune microenvironment, and therapeutic responses in hepatocellular carcinoma. Transl Oncol  2023,31,101651","journal-title":"Transl Oncol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/jcm12020486","volume":"12","author":"Lei K.","year":"2023","unstructured":"Lei K.; Deng Z.F.; Wang J.G.; You K.; Xu J.; Liu Z.J.; PNI-based nomograms to predict tumor progression and survival for patients with unresectable hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. J Clin Med  2023,12(2),486","journal-title":"J Clin Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21037\/hbsn.2018.11.19","volume":"8","author":"Zhou C.","year":"2019","unstructured":"Zhou C.; Peng Y.; Zhou K.; Zhang L.; Zhang X.; Yu L.; Hu J.; Chen F.; Qiu S.; Zhou J.; Fan J.; Ren Z.; Wang Z.; Surgical resection plus radiofrequency ablation for the treatment of multifocal hepatocellular carcinoma. Hepatobiliary Surg Nutr  2019,8(1),19-28","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1559491","DOI":"10.3389\/fonc.2025.1559491","volume":"15","author":"Meng Q.","year":"2025","unstructured":"Meng Q.; Li X.; Lang H.; Efficacy of repeat hepatectomy versus radiofrequency ablation for recurrent hepatocellular carcinoma: A Systematic Review and meta-analysis. Front Oncol  2025,15,1559491","journal-title":"Front Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1080\/14656566.2021.1953473","volume":"22","author":"Qureshi A.","year":"2021","unstructured":"Qureshi A.; Michel M.; Lerner J.; Dasanu C.A.; Evolving therapeutic strategies for advanced hepatocellular carcinoma. Expert Opin Pharmacother  2021,22(18),2495-2506","journal-title":"Expert Opin Pharmacother"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"899","DOI":"10.21037\/hbsn-22-507","volume":"11","author":"Hur M.H.","year":"2022","unstructured":"Hur M.H.; Kim Y.J.; Evolution of systemic therapy for advanced-stage hepatocellular carcinoma. Hepatobiliary Surg Nutr  2022,11(6),899-902","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"948355","DOI":"10.3389\/fsurg.2022.948355","volume":"9","author":"Dan Y.","year":"2022","unstructured":"Dan Y.; Meng W.; Li W.; Chen Z.; Lyu Y.; Yu T.; Transarterial chemoembolization combined with radiofrequency ablation versus hepatectomy for hepatocellular carcinoma: A meta-analysis. Front Surg  2022,9,948355","journal-title":"Front Surg"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"e99611","DOI":"10.5812\/iranjradiol.99611","volume":"17","author":"Yan Y.","year":"2020","unstructured":"Yan Y.; Jiang T.; Yang Z.; Wang Z.; Jin E.; Pan Z.; Application of gemstone CT spectroscopy in the evaluation of abnormal enhancement of lesion margin after radiofrequency ablation of hepatocellular carcinoma. Iran J Radiol  2020,17(4),e99611","journal-title":"Iran J Radiol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00464-015-4468-3","volume":"30","author":"Santambrogio R.","year":"2016","unstructured":"Santambrogio R.; Barabino M.; Bruno S.; Costa M.; Ceretti A.P.; Angiolini M.R.; Zuin M.; Meloni F.; Opocher E.; Long-term outcome of laparoscopic ablation therapies for unresectable hepatocellular carcinoma: A single European center experience of 426 patients. Surg Endosc  2016,30(5),2103-2113","journal-title":"Surg Endosc"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.3748\/wjg.v21.i17.5345","volume":"21","author":"Wang X.L.","year":"2015","unstructured":"Wang X.L.; Li K.; Su Z.Z.; Huang Z.P.; Wang P.; Zheng R.Q.; Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma. World J Gastroenterol  2015,21(17),5345-5351","journal-title":"World J Gastroenterol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.3748\/wjg.v28.i27.3334","volume":"28","author":"Zhou Y.","year":"2022","unstructured":"Zhou Y.; Zheng J.; Yang C.; Peng J.; Liu N.; Yang L.; Zhang X.M.; Application of intravoxel incoherent motion diffusion-weighted imaging in hepatocellular carcinoma. World J Gastroenterol  2022,28(27),3334-3345","journal-title":"World J Gastroenterol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1147111","DOI":"10.1155\/2022\/1147111","volume":"2022","author":"Zerunian M.","year":"2022","unstructured":"Zerunian M.; Pucciarelli F.; Masci B.; Siciliano F.; Polici M.; Bracci B.; Guido G.; Polidori T.; De Santis D.; Laghi A.; Caruso D.; Updates on quantitative MRI of diffuse liver disease: A narrative review. BioMed Res Int  2022,2022(1),1147111","journal-title":"BioMed Res Int"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/jmri.29086","volume":"60","author":"Wang Q.","year":"2024","unstructured":"Wang Q.; Yu G.; Qiu J.; Lu W.; Application of intravoxel incoherent motion in clinical liver imaging: A literature review. J Magn Reson Imaging  2024,60(2),417-440","journal-title":"J Magn Reson Imaging"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.acra.2018.01.010","volume":"25","author":"Shanshan L.","year":"2018","unstructured":"Shanshan L.; Feng S.; Kaikai W.; Yijun Z.; Huiming L.; Chuanmiao X.; Intravoxel incoherent motion diffusion-weighted MR imaging for early evaluation of the effect of radiofrequency ablation in rabbit liver VX2 tumors. Acad Radiol  2018,25(9),1128-1135","journal-title":"Acad Radiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0899-7071(01)00333-3","volume":"25","author":"Tsuda M.","year":"2001","unstructured":"Tsuda M.; Majima K.; Yamada T.; Saitou H.; Ishibashi T.; Takahashi S.; Hepatocellular carcinoma after radiofrequency ablation therapy. Clin Imaging  2001,25(6),409-415","journal-title":"Clin Imaging"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2463\/mrms.rev.2022-0100","volume":"22","author":"Ichikawa S.","year":"2023","unstructured":"Ichikawa S.; Goshima S.; Clinical significance of liver MR imaging. Magn Reson Med Sci  2023,22(2),157-175","journal-title":"Magn Reson Med Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00330-011-2313-1","volume":"22","author":"Dijkstra H.","year":"2012","unstructured":"Dijkstra H.; Baron P.; Kappert P.; Oudkerk M.; Sijens P.E.; Effects of microperfusion in hepatic diffusion weighted imaging. Eur Radiol  2012,22(4),891-899","journal-title":"Eur Radiol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"94959","DOI":"10.18632\/oncotarget.21824","volume":"8","author":"Li J.","year":"2017","unstructured":"Li J.; Zhang C.; Cui Y.; Liu H.; Chen W.; Wang G.; Wang D.; Intravoxel incoherent motion diffusion-weighted MR imaging of the liver using respiratory-cardiac double triggering. Oncotarget  2017,8(55),94959-94968","journal-title":"Oncotarget"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.5114\/pjr.2020.101476","volume":"85","author":"Szubert-Franczak A.E.","year":"2020","unstructured":"Szubert-Franczak A.E.; Naduk-Ostrowska M.; Pasicz K.; Podg\u00f3rska J.; Skrzy\u0144ski W.; Cieszanowski A.; Intravoxel incoherent motion magnetic resonance imaging: Basic principles and clinical applications. Pol J Radiol  2020,85,624-635","journal-title":"Pol J Radiol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/jmri.27604","volume":"54","author":"Yang J.","year":"2021","unstructured":"Yang J.; Meng M.; Pan C.; Qian L.; Sun Y.; Shi H.; Shen Y.; Dou W.; Intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging to early detect tissue injury and microcirculation alteration in hepatic injury induced by intestinal ischemia\u2013reperfusion in a rat model. J Magn Reson Imaging  2021,54(3),751-760","journal-title":"J Magn Reson Imaging"}],"container-title":["Current Medical Imaging Formerly Current Medical Imaging Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/255917","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/255917\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/255917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T09:08:30Z","timestamp":1794820110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/255917\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":20,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734056468200260622070740","relation":{},"ISSN":["1573-4056"],"issn-type":[{"value":"1573-4056","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2026-01-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e15734056468200"}}